Hyperfine, Inc. (NASDAQ:HYPR) Given Average Recommendation of “Hold” by Brokerages

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have earned an average recommendation of “Hold” from the five brokerages that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $2.0333.

Several equities analysts recently commented on the stock. B. Riley Financial restated a “buy” rating and issued a $1.60 price target (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. BTIG Research reissued a “buy” rating and issued a $2.00 price objective on shares of Hyperfine in a report on Monday, September 14th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Hyperfine in a research report on Friday, July 17th.

Institutional Investors Weigh In On Hyperfine

A number of large investors have recently added to or reduced their stakes in the stock. Catalio Capital Management LP grew its holdings in shares of Hyperfine by 92.8% during the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock worth $1,293,000 after purchasing an additional 635,500 shares in the last quarter. Renaissance Technologies LLC raised its stake in Hyperfine by 100.2% in the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after purchasing an additional 365,490 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in Hyperfine during the second quarter worth about $419,000. Tortoise Investment Management LLC lifted its position in Hyperfine by 60.0% during the fourth quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company’s stock worth $71,000 after purchasing an additional 27,000 shares during the period. Finally, Walleye Capital LLC grew its stake in Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after buying an additional 7,330 shares in the last quarter. Institutional investors and hedge funds own 15.03% of the company’s stock.

Hyperfine Price Performance

Shares of NASDAQ HYPR opened at $0.78 on Friday. The firm has a market cap of $83.22 million, a P/E ratio of -2.06 and a beta of 1.41. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. Hyperfine has a 1-year low of $0.76 and a 1-year high of $2.22. The business’s 50 day moving average is $0.90 and its 200-day moving average is $1.19.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%.The business had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. Equities research analysts predict that Hyperfine will post -0.34 earnings per share for the current year.

About Hyperfine

Hyperfine, Inc is a medical technology company that develops portable magnetic resonance imaging (MRI) systems for use at the point of care. Its flagship product, the Swoop Portable MR Imaging System, is designed to bring brain imaging directly to patients in settings such as intensive care units, emergency departments, hospitals and other clinical environments.

The Swoop system is intended to support rapid assessment of neurological conditions, including stroke, brain injury and other disorders.